These changes would compel active insurance companies to pay into a fund for medical research into the devastating asbestos disease. The Mesothelioma Act already requires insurers to fund the Diffuse Mesothelioma Payment Scheme (DMPS) which makes payments to certain mesothelioma sufferers who have good claims but who cannot obtain compensation because their employer has no assets and its insurers cannot be found. From the estimates the active insurers would have to pay about £350M over the first 10 years of the scheme's life.
Partner - Head of Occupational Health and Casualty
I am a leading insurance lawyer involved in cutting edge litigation. My expertise is in policy interpretation arising from mesothelioma claims, environmental litigation, product liability and construction cases, including a wide experience of group litigation cases.
- Tel: +44 (0)121 200 0437
- Mob: +44 (0)7824 814 631
- Email: email@example.com